Investigating new molecular containers for drug delivery and toxic substance removal
Official title: Cucurbit[n]uril-Type Molecular Containers
Funded at Univ of Maryland, College Park · NIH-10841096 · Data updated 2026-11-12
This study is looking at special tiny containers that can grab onto certain drugs and harmful substances in water, which could help make medicines work better and keep our environment safer, ultimately benefiting patients with improved treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Maryland, College Park NIH-funded |
| Lab location | 1 site (College Park, United States) |
| Project start | September 1, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $478,070 |
| NIH project number | 1R35GM153362-01 |
| Project ID | NIH-10841096 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals requiring improved drug therapies or those exposed to toxic substances.
✕Less likely to help
Patients with conditions that do not involve drug delivery issues or toxic substance exposure may not benefit from this research.
What this research studies
This research focuses on creating and understanding cucurbit[n]uril-type molecular containers that can selectively bind to cationic compounds, including drugs and harmful substances in water. By exploring the fundamental properties of these molecular containers, the research aims to demonstrate their potential in biomedical applications, such as improving drug delivery systems and detoxifying environments. Patients may benefit from advancements in targeted therapies and safer drug formulations as a result of this innovative approach.
Why it matters
Potential benefit: If successful, this research could lead to more effective drug delivery systems and methods for removing toxic substances from the body.
How similar studies have gone: Previous research in molecular containers has shown promising results in drug delivery and detoxification, indicating a strong potential for success in this area.
Where this research is happening
-
Univ of Maryland, College Park
College Park, United States Active
Researchers
- Principal investigator: Isaacs, Lyle D — Univ of Maryland, College Park
- Study coordinator: Isaacs, Lyle D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.